Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:35 PM
Ignite Modification Date:
2025-12-24 @ 9:35 PM
NCT ID:
NCT00721032
Eligibility Criteria:
Inclusion:
* Current treatment with amiodarone
* Ischemic or non-ischemic cardiomyopathy
* Monomorphic ventricular tachycardia at any cycle length, with \> 1 occurrence of the same cycle length and morphology, at least one episode needs to be of sufficient duration to result in a shock.
* No contraindication to up titration of meds or to VT radiofrequency ablation (RFA)
Exclusion:
* Primary antiarrhythmic medication other than amiodarone
* Amiodarone at dose of 600 mg daily or higher
* Polymorphic VT as culprit rhythm
* History of metal exposure (welding)
* Pregnant women
* Recent myocardial infarction
* Planned coronary revascularization
* Implantable cardiac devices not previously tested for safety in the setting of MRI
* Glomerular Filtration Rate (GFR) \< 30 ml/min
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT00721032
Study Brief:
Protocol Section:
NCT00721032